BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 23666469)

  • 21. Three Tesla magnetic resonance imaging detects oxalate osteopathy in patients with primary hyperoxaluria type I.
    Merz LM; Born M; Kukuk G; Sprinkart AM; Becker I; Martin-Higueras C; Hoppe B
    Pediatr Nephrol; 2023 Jul; 38(7):2083-2092. PubMed ID: 36472654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary and secondary hyperoxaluria: Understanding the enigma.
    Bhasin B; Ürekli HM; Atta MG
    World J Nephrol; 2015 May; 4(2):235-44. PubMed ID: 25949937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical significance of assessment of serum calcium oxalate saturation in the hyperoxaluria syndromes.
    Marangella M; Vitale C; Petrarulo M; Linari F
    Nephrol Dial Transplant; 1995; 10 Suppl 8():11-3. PubMed ID: 8592617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hyperoxaluria and renal calculi].
    Buño Soto A; Torres Jiménez R; García Puig J; Mateos Antón F
    Arch Esp Urol; 1996 Sep; 49(7):707-26. PubMed ID: 9020008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Periodontal manifestations of hyperoxaluria and oxalosis.
    Moskow BS
    J Periodontol; 1989 May; 60(5):271-8. PubMed ID: 2738833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diet and hyperoxaluria in the syndrome of idiopathic calcium oxalate urolithiasis.
    Smith LH
    Am J Kidney Dis; 1991 Apr; 17(4):370-5. PubMed ID: 2008901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amelioration of anemia after kidney transplantation in severe secondary oxalosis.
    Bernhardt WM; Schefold JC; Weichert W; Rudolph B; Frei U; Groneberg DA; Schindler R
    Clin Nephrol; 2006 Mar; 65(3):216-21. PubMed ID: 16550754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental calcium oxalate nephrolithiasis and the formation of human urinary stones.
    Khan SR
    Scanning Microsc; 1995 Mar; 9(1):89-100; discussion 100-1. PubMed ID: 8553028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal tubular injury induced by ischemia promotes the formation of calcium oxalate crystals in rats with hyperoxaluria.
    Cao Y; Liu W; Hui L; Zhao J; Yang X; Wang Y; Niu H
    Urolithiasis; 2016 Oct; 44(5):389-97. PubMed ID: 27040948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
    Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
    J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone marrow oxalosis: An unusual cause of cytopenia in end-stage renal disease; report of two cases.
    Sharma S; Rao RN; Pani KC; Paul P
    Indian J Pathol Microbiol; 2018; 61(2):268-270. PubMed ID: 29676375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperoxaluria in patients with recurrent calcium oxalate calculi: dietary and other risk factors.
    Laminski NA; Meyers AM; Kruger M; Sonnekus MI; Margolius LP
    Br J Urol; 1991 Nov; 68(5):454-8. PubMed ID: 1747716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute oxalate nephropathy causing late renal transplant dysfunction due to enteric hyperoxaluria.
    Rankin AC; Walsh SB; Summers SA; Owen MP; Mansell MA
    Am J Transplant; 2008 Aug; 8(8):1755-8. PubMed ID: 18557738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-terminal renal insufficiency in a patient with enteric hyperoxaluria: effect of medical management on renal function.
    Pipeleers L; Wissing KM; Pirson Y; Cosyns JP; Geers C; Tielemans C
    Acta Clin Belg; 2012; 67(1):39-41. PubMed ID: 22480038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone impairment in oxalosis: An ultrastructural bone analysis.
    Bacchetta J; Farlay D; Abelin-Genevois K; Lebourg L; Cochat P; Boivin G
    Bone; 2015 Dec; 81():161-167. PubMed ID: 26164477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic expression of primary hyperoxaluria: comparative features of types I and II.
    Milliner DS; Wilson DM; Smith LH
    Kidney Int; 2001 Jan; 59(1):31-6. PubMed ID: 11135054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of plasma oxalate levels by oral application of Oxalobacter formigenes in 2 patients with infantile oxalosis.
    Hoppe B; Dittlich K; Fehrenbach H; Plum G; Beck BB
    Am J Kidney Dis; 2011 Sep; 58(3):453-5. PubMed ID: 21705122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An update on primary hyperoxaluria.
    Hoppe B
    Nat Rev Nephrol; 2012 Jun; 8(8):467-75. PubMed ID: 22688746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyridoxamine lowers kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria.
    Chetyrkin SV; Kim D; Belmont JM; Scheinman JI; Hudson BG; Voziyan PA
    Kidney Int; 2005 Jan; 67(1):53-60. PubMed ID: 15610227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure.
    Hoppe B; Kemper MJ; Bökenkamp A; Portale AA; Cohn RA; Langman CB
    Kidney Int; 1999 Jul; 56(1):268-74. PubMed ID: 10411702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.